The CE Mark approval of the VitalFlow™ ECMO System marks a significant advancement in extracorporeal life support, delivering enhanced precision and control for managing critically ill cardiac and respiratory patients....
World-first deployment of AI-powered laser tech enhances medication safety in high-risk hospital settings...
Highlighting key cybersecurity challenges and readiness gaps across the evolving medical device ecosystem....
CE Mark Approval Advances Precision Thrombectomy with Vessel-Conforming Design for Improved Stroke Outcomes Across Europe...
Next-gen GLP-1 therapies and real-time biosensors are redefining metabolic care—delivering effective weight loss while preserving muscle mass, and enabling more personalized, outcome-focused treatment. ...
New app rollout enhances insulin automation and real-time glucose monitoring through seamless smartphone control....
World Economic Forum recognizes INBRAIN for its groundbreaking graphene-based brain-computer interface platform aimed at treating neurological disorders with unmatched precision....
The first-in-human use of the Sola™ Coronary Laser IVL System marks a breakthrough in coronary calcium modification, providing physicians with a novel level of precision and control in treating complex calcified lesions....
The launch of Ruby® XL represents a breakthrough in vascular embolization, offering physicians unprecedented flexibility and efficiency for complex case management. ...
With over 50,000 successful uses and backing from the Serum Institute, IntegriMedical’s N-FIS system is redefining patient comfort and safety as it expands from paediatrics to gynaecology. ...
